Table of Content


Chapter 1. Global Retinal Disorder Treatment Market Executive Summary
1.1. Global Retinal Disorder Treatment Market Size & Forecast (2022–2032)
1.2. Regional Summary
1.3. Segmental Summary
?1.3.1. By Type
?1.3.2. By Dosage Form
?1.3.3. By Distribution Channel
?1.3.4. By Product Type
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Retinal Disorder Treatment Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
?2.3.1. Inclusion & Exclusion
?2.3.2. Limitations
?2.3.3. Supply Side Analysis
??2.3.3.1. Availability
??2.3.3.2. Infrastructure
??2.3.3.3. Regulatory Environment
??2.3.3.4. Market Competition
??2.3.3.5. Economic Viability (Consumer’s Perspective)
?2.3.4. Demand Side Analysis
??2.3.4.1. Regulatory Frameworks
??2.3.4.2. Technological Advancements
??2.3.4.3. Environmental Considerations
??2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Retinal Disorder Treatment Market Dynamics
3.1. Market Drivers
?3.1.1. Aging Global Demographics & Rising AMD/DR Prevalence
?3.1.2. Advances in Biologics, Gene Therapies & Sustained-Release Delivery
?3.1.3. Expansion of Diabetic Population & Preventive Screening Initiatives
3.2. Market Challenges
?3.2.1. High Cost of Advanced Biologic Therapies
?3.2.2. Lengthy Regulatory Approvals & Reimbursement Complexities
?3.2.3. Patient Adherence Issues & Frequent Intravitreal Injections
3.3. Market Opportunities
?3.3.1. Development of Long-Acting Injectables & Refillable Implants
?3.3.2. Teleophthalmology & AI-Based Diagnostic Platforms
?3.3.3. Fixed-Dose Combinations & Co-Formulations
Chapter 4. Global Retinal Disorder Treatment Market Industry Analysis
4.1. Porter’s Five Forces Model
?4.1.1. Bargaining Power of Suppliers
?4.1.2. Bargaining Power of Buyers
?4.1.3. Threat of New Entrants
?4.1.4. Threat of Substitutes
?4.1.5. Competitive Rivalry
?4.1.6. Futuristic Adaptation of Porter’s Model
?4.1.7. Porter’s Five Forces Impact Analysis
4.2. PESTEL Analysis
?4.2.1. Political
?4.2.2. Economic
?4.2.3. Social
?4.2.4. Technological
?4.2.5. Environmental
?4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspectives
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Retinal Disorder Treatment Market Size & Forecasts by Type (2022–2032)
5.1. Segment Dashboard
5.2. Global Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Million)
?5.2.1. Macular Degeneration
?5.2.2. Diabetic Retinopathy
Chapter 6. Global Retinal Disorder Treatment Market Size & Forecasts by Dosage Form (2022–2032)
6.1. Segment Dashboard
6.2. Global Market: Dosage Form Revenue Trend Analysis, 2022 & 2032 (USD Million)
?6.2.1. Injections
?6.2.2. Tablets
?6.2.3. Eye Drops
?6.2.4. Implants
Chapter 7. Global Retinal Disorder Treatment Market Size & Forecasts by Distribution Channel (2022–2032)
7.1. Segment Dashboard
7.2. Hospital Pharmacies: Revenue Trend Analysis, 2022 & 2032 (USD Million)
7.3. Retail Pharmacies: Revenue Trend Analysis, 2022 & 2032 (USD Million)
7.4. Online Pharmacies: Revenue Trend Analysis, 2022 & 2032 (USD Million)
Chapter 8. Global Retinal Disorder Treatment Market Size & Forecasts by Product Type (2022–2032)
8.1. Segment Dashboard
8.2. Anti-VEGF Drugs: Revenue Trend Analysis, 2022 & 2032 (USD Million)
8.3. Steroid Implants: Revenue Trend Analysis, 2022 & 2032 (USD Million)
8.4. Gene Therapy Products: Revenue Trend Analysis, 2022 & 2032 (USD Million)
8.5. Others: Revenue Trend Analysis, 2022 & 2032 (USD Million)
Chapter 9. Global Retinal Disorder Treatment Market Size & Forecasts by Region (2022–2032)
9.1. North America
?9.1.1. U.S. Market
?9.1.2. Canada Market
9.2. Europe
?9.2.1. UK Market
?9.2.2. Germany Market
?9.2.3. France Market
?9.2.4. Spain Market
?9.2.5. Italy Market
?9.2.6. Rest of Europe Market
9.3. Asia Pacific
?9.3.1. China Market
?9.3.2. India Market
?9.3.3. Japan Market
?9.3.4. Australia Market
?9.3.5. South Korea Market
?9.3.6. Rest of Asia Pacific Market
9.4. Latin America
?9.4.1. Brazil Market
?9.4.2. Mexico Market
9.5. Middle East & Africa
?9.5.1. Saudi Arabia Market
?9.5.2. South Africa Market
?9.5.3. Rest of Middle East & Africa Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
?10.1.1. Novartis AG
?10.1.2. Regeneron Pharmaceuticals, Inc.
?10.1.3. Genentech, Inc. (A Member of the Roche Group)
10.2. Top Market Strategies
10.3. Company Profiles
?10.3.1. Novartis AG
??10.3.1.1. Key Information
??10.3.1.2. Overview
??10.3.1.3. Financial (Subject to Data Availability)
??10.3.1.4. Product Summary
??10.3.1.5. Market Strategies
?10.3.2. Bayer AG
?10.3.3. AbbVie Inc.
?10.3.4. Regeneron Pharmaceuticals, Inc.
?10.3.5. Genentech, Inc. (A Member of the Roche Group)
?10.3.6. Allergan (AbbVie Inc.)
?10.3.7. Alimera Sciences
?10.3.8. Bausch + Lomb
?10.3.9. Adverum Biotechnologies, Inc.
?10.3.10. IVERIC bio (Astellas)
?10.3.11. Oxurion NV
?10.3.12. Kubota Vision Inc.
?10.3.13. Johnson & Johnson Services, Inc.
?10.3.14. Pfizer Inc.
?10.3.15. Ocugen, Inc.
Chapter 11. Research Process
11.1. Research Process
?11.1.1. Data Mining
?11.1.2. Analysis
?11.1.3. Market Estimation
?11.1.4. Validation
?11.1.5. Publishing
11.2. Research Attributes



List of Figures

List of Figures
FIG 1. Global Retinal Disorder Treatment market, research methodology
FIG 2. Global market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global market, key trends 2023
FIG 5. Global market, growth prospects 2022–2032
FIG 6. Porter’s Five Forces model
FIG 7. PESTEL analysis
FIG 8. Value chain analysis
FIG 9. Market by Type, 2022 & 2032 (USD Million)
FIG 10. Market by Dosage Form, 2022 & 2032 (USD Million)
FIG 11. Market by Distribution Channel, 2022 & 2032 (USD Million)
FIG 12. Market by Product Type, 2022 & 2032 (USD Million)
FIG 13. Regional snapshot 2022 & 2032
FIG 14. North America market 2022 & 2032 (USD Million)
FIG 15. Europe market 2022 & 2032 (USD Million)
FIG 16. Asia Pacific market 2022 & 2032 (USD Million)
FIG 17. Latin America market 2022 & 2032 (USD Million)
FIG 18. Middle East & Africa market 2022 & 2032 (USD Million)
FIG 19. Company market share analysis (2023)
FIG 20. Teleophthalmology & AI platform adoption trends (2023)

List of Tables

List of Tables
TABLE 1. Global Retinal Disorder Treatment market, report scope
TABLE 2. Global Retinal Disorder Treatment market estimates & forecasts by Region 2022–2032 (USD Million)
TABLE 3. Global Retinal Disorder Treatment market estimates & forecasts by Type 2022–2032 (USD Million)
TABLE 4. Global Retinal Disorder Treatment market estimates & forecasts by Dosage Form 2022–2032 (USD Million)
TABLE 5. Global Retinal Disorder Treatment market estimates & forecasts by Distribution Channel 2022–2032 (USD Million)
TABLE 6. Global Retinal Disorder Treatment market estimates & forecasts by Product Type 2022–2032 (USD Million)
TABLE 7. Global Retinal Disorder Treatment market by segment, estimates & forecasts, 2022–2032 (USD Million)
TABLE 8. Global Retinal Disorder Treatment market by region, estimates & forecasts, 2022–2032 (USD Million)
TABLE 9. U.S. Retinal Disorder Treatment market estimates & forecasts, 2022–2032 (USD Million)
TABLE 10. U.S. market estimates & forecasts by segment 2022–2032 (USD Million)
TABLE 11. Canada market estimates & forecasts 2022–2032 (USD Million)
TABLE 12. Canada market estimates & forecasts by segment 2022–2032 (USD Million)
TABLE 13. UK market estimates & forecasts 2022–2032 (USD Million)
TABLE 14. Germany market estimates & forecasts 2022–2032 (USD Million)
TABLE 15. France market estimates & forecasts 2022–2032 (USD Million)
TABLE 16. Spain market estimates & forecasts 2022–2032 (USD Million)
TABLE 17. Italy market estimates & forecasts 2022–2032 (USD Million)
TABLE 18. Asia Pacific market estimates & forecasts 2022–2032 (USD Million)
TABLE 19. Latin America market estimates & forecasts 2022–2032 (USD Million)
TABLE 20. Middle East & Africa market estimates & forecasts 2022–2032 (USD Million)